Clinical Study | Office of Clinical Research

Phase III Trial Of Dose Escalation Radiation Therapy And Standard Androgen Deprivation Therapy With A Gnrh Agonist Vs. Dose Escalated Radiation Therap

Posted Date: May 15, 2019

Investigator: Jordan Kharofa
Type of Study: Drug

This study will compare the good and bad effects of hormone therapy and TAK-700 plus radiation therapy with hormone therapy and radiation therapy on prostate cancer to find out which is better. Tak-700 is an investigational drug, not approved by the FDA. It is intended to further reduce the levels o

Criteria:

Eligible Patients Must Have Prostate Cancer

Keywords:

Genitourninary Cance, High Risk, Prostate Cancer, R1115

For More Information:

Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List